Yao Chang Xu
Chief Executive Officer bei ABBISKO CAYMAN LIMITED
Vermögen: 35 Mio $ am 30.04.2024
Aktive Positionen von Yao Chang Xu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ABBISKO CAYMAN LIMITED | Chief Executive Officer | 28.03.2018 | - |
| Chairman | 28.03.2018 | - | |
| Founder | 12.04.2016 | - | |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Chief Executive Officer | 12.04.2016 | - |
| Chairman | 12.04.2016 | - | |
| Founder | 12.04.2016 | - | |
| Abbisko Hong Kong Ltd. | Director/Board Member | 01.04.2018 | - |
| Wuxi Abbisko Biomedical Technology Co. Ltd. | Director/Board Member | 01.07.2020 | - |
| Abbisko Therapeutics Australia Pty Ltd. | Director/Board Member | 01.12.2020 | - |
Karriereverlauf von Yao Chang Xu
Ehemalige bekannte Positionen von Yao Chang Xu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | Corporate Officer/Principal | 01.03.2012 | 01.03.2016 |
| Shanghai Hansoh Biomedical Co. Ltd. | Corporate Officer/Principal | 01.03.2012 | 01.03.2016 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Director/Board Member | 01.01.2006 | 01.03.2012 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.10.1993 | 01.01.2006 |
Ausbildung von Yao Chang Xu
| The University of Chicago | Doctorate Degree |
| Nanjing University | Undergraduate Degree |
Statistik
International
| China | 7 |
| Vereinigte Staaten | 3 |
| Schweiz | 2 |
Operativ
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | Health Technology |
| ABBISKO CAYMAN LIMITED | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Health Technology |
| Shanghai Hansoh Biomedical Co. Ltd. | |
| Abbisko Hong Kong Ltd. | |
| Wuxi Abbisko Biomedical Technology Co. Ltd. | |
| Abbisko Therapeutics Australia Pty Ltd. |
- Börse
- Insiders
- Yao Chang Xu
- Erfahrung
